Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Acta Obstétrica e Ginecológica Portuguesa
versión impresa ISSN 1646-5830
Resumen
VEIGA, Vera; CORREIA, Lúcia; GOMES, António y JORGE, Ana Francisca. Hormonal therapy post ovarian cancer treatment: yes or no?. Acta Obstet Ginecol Port [online]. 2019, vol.13, n.1, pp.40-46. ISSN 1646-5830.
The mean age of diagnosis of ovarian epithelial tumors is 63 years, but 3-17% affects women under the age of 40 years. In this age group, standard treatment conditions an iatrogenic menopause, so that conservative therapeutic options are increasingly weighted at early ages. Estrogen therapy is the most effective treatment for the symptoms associated with menopause, but doubts about its use in these women are frequent. The review of the literature shows that after treatment of ovarian cancer, the use of hormone therapy does not influence relapse rates nor overall survival.
Palabras clave : Ovary cancer; Hormonal; Contraception; Recurrence; Receptors.